4.6 Review

AMP-activated protein kinase and cancer

Journal

ACTA PHYSIOLOGICA
Volume 196, Issue 1, Pages 55-63

Publisher

WILEY
DOI: 10.1111/j.1748-1716.2009.01980.x

Keywords

AMPK; autophagy; cancer; cell polarity; hypoxia; LKB1; p53

Categories

Funding

  1. NIH

Ask authors/readers for more resources

AMP-activated protein kinase (AMPK) is a cellular energy sensor that is conserved in eukaryotes. Elevated AMP/ATP ratio activates AMPK, which inhibits energy-consuming processes and activates energy-producing processes to restore the energy homeostasis inside the cell. AMPK activators, metformin and thiazolidinediones, are used for the treatment of type II diabetes. Recently, reports have indicated that AMPK may also be a beneficial target for cancer treatment. Cancer cells have characteristic metabolic changes different from normal cells and, being a key metabolic regulator, AMPK may regulate the switch. AMPK may act to inhibit tumorigenesis through regulation of cell growth, cell proliferation, autophagy, stress responses and cell polarity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available